Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-23-020070
Filing Date
2023-04-25
Accepted
2023-04-25 09:01:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 ny20008758x3_424b3.htm 424B3 240474
  Complete submission text file 0001140361-23-020070.txt   241774
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271279 | Film No.: 23841913
SIC: 2834 Pharmaceutical Preparations